+321 123 4567
info@test.com
My Account
  • Home
  • News
    • Publications
    • Videos
  • About
    • The ASCENT project
    • Digital Adherence Technologies
    • Our Approach
    • Our Team
    • Funding & support
    • Consortium Partners
  • Countries
    • Ethiopia
    • South Africa
    • Tanzania
    • The Philippines
    • Ukraine
  • Market
    • Market landscape
    • Market size
    • Market Growth
      • DAT use beyond TB
      • DAT user growth
      • Optimal DAT design
  • Products
    • Adherence Platforms
  • Resources
  • connect with us

ASCENT Ethiopia, Research Results Dissemination and Closeout Event

2 years ago
ASCENT, Ethiopia
175 Comments

Results from Ethiopia reflect the usability and acceptability of DATs by TB care providers and people with TB, indicating the potential for wider adoption of DATs to support the TB care cascade throughout the region.

Read More

ASCENT Ethiopia presented DATs at the National Health Exhibition for six weeks

2 years ago
Ethiopia
52 Comments

The national health exhibition organizing committee selected the ASCENT project for the National Health Exhibition to present Digital Adherence Technology.

Read More

Video: How Nugusse from Ethiopia got cured from tuberculosis using the smart pillbox

2 years ago
Ethiopia
48 Comments

Nugusse, who rides horse drawn carriages for a living in Ethiopia, successfully completed his tuberculosis (TB) treatment using a digital adherence technology (DAT), provided by the ASCENT project.

Read More

Video: Tsedale from Ethiopia demonstrates the use of the medication label/sleeve for TB treatment

3 years ago
Ethiopia
56 Comments

In this video, made in Ethiopia, Tsedale explains the advantages she experienced using a DAT, the medication sleeve/label, in comparison to DOT.

Read More

“With the smart pillbox alarm, it is impossible to forget your medication”, a TB patient treated in Ethiopia using DAT

3 years ago
Ethiopia
17 Comments

A tuberculosis survivor named Netsanet, a 35-year-old mother of three, explained her experience on the use of digital adherence technology for her treatment.

Read More

ASCENT Ethiopia held review meeting to discuss project progress & transition plan for sustainability and scale-up

3 years ago
Ethiopia
13 Comments

ASCENT Ethiopia conducted a review meeting to discuss project implementation and research progress and the transition plan for sustainability and scale-up.

Read More

ASCENT Ethiopia conducted an orientation meeting for Civil Society Organization members

3 years ago
Ethiopia
6 Comments

ASCENT in Ethiopia conducted an orientation meeting on digital adherence technologies for civil society organization members to ensure community engagement activities.

Read More

ASCENT Ethiopia conducts review meeting to improve assistance for tuberculosis patients

4 years ago
Ethiopia
17 Comments

ASCENT Ethiopia conducted a one-day review meeting in Bishoftu town Gold Mark Hotel for better implementation of the project.

Read More

Tuberculosis patient about smart pillbox: “It’s like having a private doctor!”

4 years ago
Ethiopia
16 Comments

Mehamed is a father of one daughter, husband and merchant of used clothes. He lives in Addis Ababa (Ethiopia) and was diagnosed with tuberculosis (TB) at the age of 27. Shortly after his diagnosis, he started his treatment supported by a smart pillbox provided by the ASCENT project, funded by Unitaid and led by KNCV Tuberculosis Foundation.

Read More

The Community Advisory Board for the ASCENT project is established

5 years ago
Ethiopia
18 Comments

The Community Advisory Board (CAB) for the ASCENT project in Ethiopia was established to guard the safety and well-being of beneficiaries/study participants.

Read More

THE ASCENT PROJECT

The ASCENT project helps people affected with TB successfully complete their treatment through the use of digital adherence technologies and data-driven support interventions, utilizing smart pill boxes and other innovations.

Sign up to our newsletter

connect with us

Twitter
Facebook

This project is made possible thanks to
Unitaid funding and support.

Disclaimer – Privacy and Cookie statement